IL85688A0 - Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them - Google Patents

Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL85688A0
IL85688A0 IL85688A IL8568888A IL85688A0 IL 85688 A0 IL85688 A0 IL 85688A0 IL 85688 A IL85688 A IL 85688A IL 8568888 A IL8568888 A IL 8568888A IL 85688 A0 IL85688 A0 IL 85688A0
Authority
IL
Israel
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
immunoglobulin conjugates
conjugates
Prior art date
Application number
IL85688A
Other languages
English (en)
Original Assignee
Erba Carlo Spa
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa, Univ Melbourne filed Critical Erba Carlo Spa
Publication of IL85688A0 publication Critical patent/IL85688A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL85688A 1987-03-11 1988-03-10 Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them IL85688A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI080387 1987-03-11
AUPI295587 1987-07-07

Publications (1)

Publication Number Publication Date
IL85688A0 true IL85688A0 (en) 1988-08-31

Family

ID=25643244

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85688A IL85688A0 (en) 1987-03-11 1988-03-10 Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US5798097A (da)
JP (1) JP2736255B2 (da)
KR (1) KR0130906B1 (da)
CN (1) CN1045621C (da)
AT (1) AT395375B (da)
AU (1) AU622105B2 (da)
BE (1) BE1001051A4 (da)
CA (1) CA1329156C (da)
CH (1) CH678815A5 (da)
CZ (1) CZ161288A3 (da)
DE (1) DE3808166C2 (da)
DK (1) DK173792B1 (da)
ES (1) ES2006109A6 (da)
FI (1) FI98706C (da)
FR (1) FR2612074B1 (da)
GB (1) GB2203154B (da)
GR (1) GR1000059B (da)
HU (1) HU205266B (da)
IE (1) IE64781B1 (da)
IL (1) IL85688A0 (da)
IT (1) IT8819746A0 (da)
MY (1) MY103231A (da)
NL (1) NL8800610A (da)
NO (1) NO178954C (da)
NZ (1) NZ223834A (da)
PT (1) PT86960B (da)
RU (1) RU2106147C1 (da)
SE (1) SE503402C2 (da)
YU (1) YU46858B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) * 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
CN100340291C (zh) * 1998-10-09 2007-10-03 路德维格癌症研究院 F1t4(VEGFR－3)作为肿瘤显像和抗肿瘤治疗的靶
AU2002216864A1 (en) * 2000-12-21 2002-07-01 Mcgill University Conjugates of antibodies and anticancer drugs
AU2002248372B8 (en) 2001-01-19 2008-03-20 Vegenics Limited FLT4(VEGFR-3) as a target for tumor imaging and anti-tumor therapy
CA2522700A1 (en) * 2003-04-18 2004-11-04 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
PT2646470T (pt) 2010-11-30 2017-05-03 Hoffmann La Roche Anticorpos anti-recetor da transferrina de baixa afinidade e a sua utilização na transferência de scfv terapêuticos através da barreira hematoencefálica
CA2901226C (en) 2013-02-18 2020-11-17 Vegenics Pty Limited Vascular endothelial growth factor binding proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT346838B (de) * 1975-01-22 1978-11-27 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
AT343812B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen
AT343811B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1511680A (en) 1975-11-18 1978-05-24 Farmaceutici Italia Daunosaminyl anthracyclinones
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
US4950738A (en) * 1984-09-13 1990-08-21 Cytogen Corporation Amine derivatives of anthracycline antibiotics
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB8413464D0 (en) * 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
JPS61155334A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 殺細胞性修飾免疫グロブリン及びその製造方法
FR2584293B1 (fr) * 1985-07-04 1989-03-17 Ire Celltarg Sa Anticorps utiles comme agents de pilotage et conjugues les incorporant

Also Published As

Publication number Publication date
HUT46547A (en) 1988-11-28
FI881158A0 (fi) 1988-03-11
FR2612074A1 (fr) 1988-09-16
CH678815A5 (da) 1991-11-15
NO178954C (no) 1996-07-10
CA1329156C (en) 1994-05-03
AT395375B (de) 1992-12-10
FI98706C (fi) 1997-08-11
YU48288A (en) 1989-08-31
SE8800886D0 (sv) 1988-03-11
DE3808166C2 (de) 1997-08-28
CZ281193B6 (cs) 1996-07-17
DK173792B1 (da) 2001-11-05
GB2203154A (en) 1988-10-12
GB8805865D0 (en) 1988-04-13
PT86960A (pt) 1988-04-01
JP2736255B2 (ja) 1998-04-02
KR880010775A (ko) 1988-10-24
SE8800886L (sv) 1989-09-12
NL195078C (da) 2003-07-30
NZ223834A (en) 1990-05-28
IE64781B1 (en) 1995-09-06
NO881105L (no) 1988-09-12
CZ161288A3 (en) 1996-07-17
PT86960B (pt) 1992-06-30
DE3808166A1 (de) 1988-09-22
BE1001051A4 (fr) 1989-06-20
ATA67488A (de) 1992-05-15
ES2006109A6 (es) 1989-04-01
NL8800610A (nl) 1988-10-03
IT8819746A0 (it) 1988-03-11
YU46858B (sh) 1994-06-24
FR2612074B1 (fr) 1991-06-21
GR1000059B (el) 1990-06-27
GB2203154B (en) 1991-06-26
NO881105D0 (no) 1988-03-11
US5798097A (en) 1998-08-25
NO178954B (no) 1996-04-01
SE503402C2 (sv) 1996-06-10
DK131588A (da) 1988-09-12
RU2106147C1 (ru) 1998-03-10
HU205266B (en) 1992-04-28
FI98706B (fi) 1997-04-30
KR0130906B1 (ko) 1998-04-23
AU622105B2 (en) 1992-04-02
CN1045621C (zh) 1999-10-13
CN88101810A (zh) 1988-11-09
MY103231A (en) 1993-05-29
JPS63301832A (ja) 1988-12-08
DK131588D0 (da) 1988-03-11
FI881158A (fi) 1988-09-12
GR880100148A (en) 1989-01-31
IE880701L (en) 1988-09-11
AU1288188A (en) 1988-09-15

Similar Documents

Publication Publication Date Title
IL95155A0 (en) 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them
IL95640A0 (en) 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL88156A0 (en) Azacyclic compounds,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL94556A0 (en) Hydroxypropylamines,their preparation and pharmaceutical compositions containing them
IL84302A (en) Substituted :-aminoacids, their preparation and pharmaceutical compositions containing them
IL98499A0 (en) Aminobenzodiazepines,their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL86033A0 (en) Substituted pyrroles,their preparation and pharmaceutical compositions containing them
IL89778A (en) Unsaturated n-benzopyranyllactams, their preparation and pharmaceutical compositions containing them
IL85688A0 (en) Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them
IL75966A (en) 3-substituted-1-aminoalkyl-1h-indoles,their preparation and pharmaceutical compositions containing them
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
IL86478A (en) Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
IL88237A0 (en) Fluoromethoxyphenyl dihydropyridines,their preparation and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
DE3573784D1 (en) Carboxyalkyldipeptides, their preparation and pharmaceutical compositions containing them
IL95563A0 (en) Substituted amino-pyridines,their preparation and pharmaceutical compositions containing them
IL85824A (en) Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them
IL88311A0 (en) 4-demethoxy anthracycline derivatives,their preparation and pharmaceutical compositions containing them
IL84633A0 (en) 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HCE Change of name and address of proprietor(s)
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
NF Patent restored
KB Patent renewed
KB Patent renewed
EXP Patent expired